Top Story

One in four patients with head, neck cancers do not receive guideline-directed adjuvant therapy

September 2, 2014

About 25% of patients with surgically resected head and neck cancers that exhibit adverse pathologic features do not receive guideline-directed adjuvant therapy with chemoradiation or radiotherapy, according to study results.

Researchers reported lower rates of adjuvant therapy use at academic and high-volume centers, suggesting considerable heterogeneity in physician practices. Patient-level factors also are associated with variations in receipt of adjuvant therapy.

In the Journals

Surgery improved outcomes in advanced laryngeal cancer

August 26, 2014
Patients with advanced laryngeal cancer who underwent surgery experienced longer disease-specific survival and OS than those treated with nonsurgical therapy, according…
In the JournalsPerspective

Researchers identify risk factors for soft tissue necrosis in OSCC

August 19, 2014
A specific subset of patients with oropharyngeal squamous cell carcinoma who undergo transoral robotic surgery and postoperative radiotherapy demonstrated an increased…
Industry News

PDI, Inc. subsidiary acquires thyroid, cancer diagnostic tests

August 17, 2014
Continuing its path in commercializing molecular diagnostic tests, PDI, Inc. announced its Interpace Diagnostics subsidiary has acquired the miRInform Thyroid and…
CME

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

8/16/2014
Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
CME CNE

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

8/20/2014
MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »

Filter By:

figure In the Journals

One in four patients with head, neck cancers do not receive guideline-directed adjuvant therapy

September 2, 2014
About 25% of patients with surgically resected head and neck cancers that exhibit adverse pathologic features do not receive guideline-directed…
In the Journals

Surgery improved outcomes in advanced laryngeal cancer

August 26, 2014
Patients with advanced laryngeal cancer who underwent surgery experienced longer disease-specific survival and OS than those treated with nonsurgical…
In the Journals Perspective

Researchers identify risk factors for soft tissue necrosis in OSCC

August 19, 2014
A specific subset of patients with oropharyngeal squamous cell carcinoma who undergo transoral robotic surgery and postoperative radiotherapy…
Industry News

PDI, Inc. subsidiary acquires thyroid, cancer diagnostic tests

August 17, 2014
Continuing its path in commercializing molecular diagnostic tests, PDI, Inc. announced its Interpace Diagnostics subsidiary has acquired the…
figure In the Journals Perspective

Blood, saliva testing may predict recurrence of HPV-related head and neck cancers

August 13, 2014
Testing for HPV-16 DNA in saliva and plasma may be a useful predictor of recurrence in patients with oropharyngeal squamous cell carcinoma, according…
In the Journals

Co-existence of BRAF V600E, TERT promoter mutations predict recurrence in papillary thyroid cancer

August 1, 2014
Patients with papillary thyroid cancer who harbor BRAF V600E mutation and a specific telomerase reverse transcriptase promoter mutation are at…
Industry News

Thyroid association recognizes research grant collaboration of patient support groups

July 27, 2014
The American Thyroid Association has allied with Bite Me Cancer, a thyroid cancer patient support group, to deliver a newly awarded grant in…
figure Cover Stories Publication Exclusive

Liquid biopsies provide extensive information, but technology carries ‘potential for overuse’

HemOnc Today, July 25, 2014
Researchers have known for decades that tumors shed cells and DNA into the bloodstream.
In the Journals Perspective

Diabetes increased risk for head, neck cancers

July 24, 2014
Patients with diabetes demonstrated an increased risk for head and neck cancers, particularly malignancies of the oral cavity, oropharynx and…
In the Journals

Induction, chemoradiation regimen effective for stage III/IV head and neck cancers

July 21, 2014
Induction treatment with cetuximab, paclitaxel and carboplatin, followed by chemoradiation with the same combination, induced high rates of primary…
More Headlines »